SCHEMBL23052016

SCHEMBL23052016

O=S(=O)(NCCC1=CCCCC1)c1cccs1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.60
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
TDP1 Q9NUW8 1/20 0.57
ALDH1A1 P00352 5/20 0.56
ALOX15 P16050 2/20 0.56
PKM P14618 1/20 0.54
HTT P42858 1/20 0.54
NPSR1 Q6W5P4 3/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54
POLB P06746 1/20 0.52
TSHR P16473 2/20 0.51
KMT2A Q03164 2/20 0.49
RECQL P46063 1/20 0.49
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23051998 0.78 TDP1 (0.75) L3MBTL1TDP1ALDH1A1ALOX15HTT
SCHEMBL23045594 0.74 TDP1 (0.72) L3MBTL1TDP1ALDH1A1ALOX15HTT
SCHEMBL16221401 0.73 TDP1 (0.76) L3MBTL1TDP1ALDH1A1ALOX15NPSR1
SCHEMBL7217749 0.73 CYP2D6 (0.72) CYP2D6CYP2C9CYP2C19TDP1ALDH1A1
SCHEMBL23052287 0.72 TDP1 (0.65) L3MBTL1TDP1ALDH1A1ALOX15HTT
SCHEMBL6127516 0.72 CYP2D6 (0.82) L3MBTL1CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL6127693 0.72 CYP2D6 (0.82) L3MBTL1CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL23023146 0.71 TP53 (0.48) L3MBTL1ALDH1A1ALOX15HTTKDM4E
SCHEMBL7194116 0.70 CYP2D6 (0.79) L3MBTL1CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL5652601 0.70 CYP2D6 (0.79) L3MBTL1CYP2D6CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021039824-A1 RNA METHYLTRANSFERASE INHIBITOR, SCREENING METHOD THEREFOR, ANTI-CANCER AGENT EFFICACY ASSESSMENT MARKER, AND KIT FOR EFFECTIVELY PREDICTING FTSJ1 INHIBITOR 国立大学法人 岡山大学 2021-03-04 WO disclosed